TRXC News and Press, TransEnterix Inc. From 12/11/19

TransEnterix, Inc. (NYSE American: TRXC) today announced that, following approval of a reverse stock split range and authorized share reduction by stockholders at a special meeting of stockholders earlier today, the TransEnterix’s Board of Directors determined to effect a reverse stock...

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced it will host a surgeon panel discussion and Senhance technology demonstration via live webcast on Frid...

This article was selected to be shared with PRO+ Short Ideas subscribers - find out more here . Enochian Biosciences ( ENOB ) is a biotech company with a pre-clinical pipeline focused on the treatment and cure of HIV. Enochian has a troubled past, with a lot of management shake-ups and ...

TransEnterix, Inc. (TRXC) Q3 2019 Results Earnings Conference Call November 12, 2019, 04:30 PM ET Company Participants Mark Klausner - Westwicke Partners Paul LaViolette - Chairman of the Board of Directors Anthony Fernando - President & Chief Executive Officer Joseph Slatt...

The following slide deck was published by TransEnterix, Inc. in conjunction with their 2019 Q3 earnings Read more ...

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of 2019 and provided a business update. ...

Are These 3 Penny Stocks A Buy Right Now; or Sell? While most people are off of work on Veteran’s day, hustlers in the stock market are up bright and early. The markets don’t rest on Veteran’s day, but bankers do, and I won’t be one to complain about making money. I...

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the repayment of all amounts owed under the loan agreement with Hercules Capital, Inc. (“Hercules...

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that the Company’s Board of Directors has appointed Anthony Fernando, the Company’s current Ch...

TransEnterix, Inc. (NYSEAmerican: TRXC) announced today that it plans to release third quarter financial and operating results after the market closes on Tuesday, November 12, 2019. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same da...